Dr Mike Baxter
Therapy Medical Expert - Diabetes, Sanofi
Dr. Mike Baxter completed a Bsc and PhD in Biochemistry at Birmingham University 1973 - 1979. He then went on to study medicine at Nottingham University 1979 - 1984 and from a very early stage knew he wanted to specialise in diabetes treatment. Mike then went on to hold a variety of posts at some of the Country's top units including Brompton, Hammersmith and Birmingham University Hospitals, before being appointed as a Consultant Physician with special interest in Endocrinology & Diabetology at St Peters Hospital, Chertsey in 1992.
It was here at St Peters that he set up a successful Diabetes Service, and held various positions in the hospital as Clinical Director of Medicine, Medical Director and Deputy CEO.
Mike retired from NHS clinical practice in 2012 but continues to run a successful private practice. Mike is currently working within the pharmaceutical industry for Sanofi as the UK & Northern Ireland medical therapy expert for diabetes. Mike continues to lecture and publish in the area of diabetes and diabetes care delivery.
Prof. Adam Cunningham
Professor of Functional Immunity, University of Birmingham
Prof. Adam Cunningham completed an
undergraduate degree in Pathology at the
University of Reading in 1991. He was awarded
his PhD in Southampton in 1995 and after a
short stay in The Gambia working at the MRC
Centre in Fajara, Adam came to Birmingham in
the summer of 1995.
His first post-doctoral position, as part of the (then) Glaxo Wellcome Action TB initiative, examined how Mycobacterium tuberculosis adapted to changes in oxygen tension. In 1999 he undertook a post-doctoral position with Prof. Ian MacLennan examining how antibody responses develop and are regulated. This led to his first independent position in Birmingham in January 2005 as a tenure-track RCUK Roberts Academic Fellow studying how immune responses develop to pathogens and vaccines.
Adam was made Senior Research Fellow in October 2009, Senior Lecturer in June 2010, Reader in October 2010 and Professor of Functional Immunity in August 2011.
Adam's contributions to recent COVID-19- relevant research have led to the development of a new ELISA test to detect antibodies to SARS-CoV-2, shown the test can confirm SARS-CoV-2 infection in children diagnosed with a newly identified multi-system inflammatory syndrome (PIMS-TS), shown the level of previous infection can vary in different health care workers in a hospital setting, and identified how antibodies can be obtained from blood spots on paper - providing a cheap and scalable way to enhance antibody testing in high and low income settings.
Prof. David Russell-Jones
Professor of Diabetes and Endocrinology, University of Surrey
Prof. David Russell-Jones Qualified from Guy's
and St Thomas' Hospital medical school in 1985.
He went on to become a Senior lecturer at Guy's
and St Thomas' and Consultant Physician.
In 1998 he was appointed Professor of Diabetes and Endocrinology at the University of Surrey and consultant physician at the Royal Surrey County Hospital. His department has since attracted large research grants and has been highly rated in the University assessment exercise.
David's research interests include the use of stable isotopes to understand peptide hormone physiology and The Wolfson Foundation funded his mass spectrometry unit.
David has also been principal investigator on a number of international clinical trials. He has published widely on insulin, GLP-1 RAs, IGF-I and Growth Hormone. He has been invited speaker at many International meetings including DUK, EASD, ADA and GRS.
During the Corona virus pandemic David was asked to set up a Covid-19 ward and has published on the disease.